Furthermore, the prosurvival proteins Bcl-2 and Bcl-xL have been described to be upregulated in initial and recurrent glioblastoma patients, whereas downregulation of the pro-apoptotic protein Bax has been observed (Strik et al., 1999). This evidence concerns the gene BAX and glioblastoma.